⌘K

Login Start Free

Home/Filings/4/0001140361-18-044399

4//SEC Filing

Marshall Ken W. 4

Accession 0001140361-18-044399

CIK 0001398733other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:01 PM ET

Size

4.5 KB

Accession

0001140361-18-044399

Insider Transaction Report

Form 4

Period: 2018-11-21

Aquestive Therapeutics, Inc.AQST

Marshall Ken W.

Commercial Leader

Transactions

Purchase
Common Stock
2018-11-21$10.15/sh+1,445$14,667→ 1,445 total(indirect: See Footnote)

Footnotes (1)

[F1]Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1

filerCIK 0001740092

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 4:01 PM ET
Size: 4.5 KB

View on SEC.gov